{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:56:27Z","timestamp":1772715387892,"version":"3.50.1"},"reference-count":25,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Scientific World Journal"],"published-print":{"date-parts":[[2021,8,17]]},"abstract":"<jats:p>With expanding pediatric antiretroviral therapy access, children will begin to experience treatment failure and require second-line therapy. In resource-limited settings, treatment failure is often diagnosed based on the clinical or immunological criteria which occur way after the occurrence of virological failure. Previous limited studies have evaluated immunological and clinical failure without considering virological failure in Ethiopia. The aim of this study was to investigate time to first-line antiretroviral treatment failure and its predictors in Shashamene town health facilities with a focus on virological criteria. Methods. A retrospective cohort study was conducted in three health facilities of Shashamene town, Oromia Regional State, from March 1 to 26, 2019. Children aged less than 15 years living with HIV\/AIDS that were enrolled on ART between January 1, 2011, and December 30, 2015, in Shashamene town health facilities were the study population. Data were extracted using a checklist, entered into EpiData version 3.1, and exported to SPSS version 20 for data analysis. Cox proportional hazard regression was used to determine the predictors of time to first-line treatment failure. Result. The median survival time to virological failure was 30 months with IQR of 24.42 to 44.25. Baseline WHO stages 3 and 4 with AHR\u2009=\u20095.69 (95% CI: 2.07\u201315.66) and NVP-based NNRT at initial treatment with AHR\u2009=\u20092.72 (1.13\u20136.54) were the independent predictors of time to treatment failure. Conclusion. The median survival time of first-line antiretroviral treatment failure was moderate in the study area as compared to other studies. The incidence density of treatment failure in this study was low as compared to other studies. The finding also demonstrated that children treated with nevirapine-based nonnucleoside reverse transcriptase inhibitors at initial and advanced WHO clinical stages at baseline were at higher risk of treatment failure.<\/jats:p>","DOI":"10.1155\/2021\/8868479","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T17:50:40Z","timestamp":1629309040000},"page":"1-9","source":"Crossref","is-referenced-by-count":6,"title":["Time to First-Line Antiretroviral Treatment Failure and Its Predictors among HIV-Positive Children in Shashemene Town Health Facilities, Oromia Region, Ethiopia, 2019"],"prefix":"10.1155","volume":"2021","author":[{"given":"Endale","family":"Zenebe","sequence":"first","affiliation":[{"name":"Jimma University, College of Public Health and Medical Science, Department of Epidemiology, Jimma, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-7867","authenticated-orcid":true,"given":"Assefa","family":"Washo","sequence":"additional","affiliation":[{"name":"Hawassa College of Health Science, Department of Public Health, Hawassa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-9839","authenticated-orcid":true,"given":"Abreham","family":"Addis Gesese","sequence":"additional","affiliation":[{"name":"Jimma University, College of Public Health and Medical Science, Department of Epidemiology, Jimma, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"1","volume-title":"Taking Stock\u202f: HIV in Children\u202f: The State of Affairs","author":"E. Ek","year":"2006"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v12i3.8"},{"key":"3","article-title":"Panel on antiretroviral therapy and medical management of children living with HIV. guidelines for the use of antiretroviral agents in pediatric HIV infection","year":"2016"},{"key":"4","volume-title":"ART Failure and Strategies for Switching ART Regimens in the WHO European Region","author":"World Health Organization Report","year":"2007"},{"key":"5","first-page":"537","article-title":"Factors associated with first-line antiretroviral therapy failure amongst HIV-infected African patients\u202f: a case-control","volume":"19","author":"A. Mwangi","year":"2014","journal-title":"BMC Infectious Disease"},{"issue":"1","key":"6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jpids\/piu032","article-title":"Predictors of treatment failure in HIV-positive children receiving combination antiretroviral therapy\u202f: cohort data from Mozambique and Uganda","volume":"4","author":"P. Costenaro","year":"2018","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-1884-y"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013528"},{"issue":"5","key":"9","article-title":"AIDS & clinical rate of immunological failure and its predictors among patients on highly active antiretroviral therapy at debremarkos hospital, Northwest Ethiopia\u202f: a retrospective follow up study","volume":"4","author":"Y. A. Melsew","year":"2013","journal-title":"Journal of AIDS & Clinical Research"},{"key":"10","volume-title":"Global Action Plan on HIV Drug Resistance 2017\u20132021","author":"A. Plan","year":"2017"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10203"},{"issue":"12","key":"12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/QAD.0000000000000707","article-title":"Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation Sophie","volume":"29","author":"S. Desmonde","year":"2018","journal-title":"AIDS (London, England)"},{"key":"13","volume-title":"Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease","author":"World Health Organization Report","year":"2006"},{"key":"14","volume-title":"Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity","author":"World Health Organization","year":"2011"},{"key":"15","volume-title":"Health of. National Guidelines for Comprehensive HIV Prevention, Care and Treatment","author":"Federal Ministry of Health","year":"2017"},{"issue":"11","key":"16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5897\/IJMMS2015.1164","article-title":"Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University hospital, retrospective cohort study","volume":"8","author":"A. Zeleke","year":"2016","journal-title":"International Journal of Medicine and Medical Sciences"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis433"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.4236\/wja.2012.24036"},{"key":"19","first-page":"1","article-title":"Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland","volume":"450","author":"K. Jobanputra","year":"2015","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-197"},{"key":"21","author":"S. Hussain","year":"2012"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019181"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0b013e3182060610"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0b013e31814278c0"},{"issue":"4","key":"25","first-page":"368","volume":"54","author":"S. D. Emmett","year":"2014","journal-title":"Study"}],"updated-by":[{"DOI":"10.1155\/tswj\/9820382","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000}}],"container-title":["The Scientific World Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/tswj\/2021\/8868479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/tswj\/2021\/8868479.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/tswj\/2021\/8868479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T17:50:56Z","timestamp":1629309056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/tswj\/2021\/8868479\/"}},"subtitle":[],"editor":[{"given":"Jacek","family":"Karwowski","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":25,"alternative-id":["8868479","8868479"],"URL":"https:\/\/doi.org\/10.1155\/2021\/8868479","relation":{},"ISSN":["1537-744X","2356-6140"],"issn-type":[{"value":"1537-744X","type":"electronic"},{"value":"2356-6140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,17]]}}}